Pharmaceutical caps and closures are widely used for sealing pharmaceutical primary packaging such as bottles, vials, and ampoules. They play a crucial role in protecting the pharmaceutical products from external contaminants and prevent loss of potency. Caps and closures ensure product safety and quality throughout the product lifespan by providing an effective and tamper-proof seal. There has been increased adoption of caps and closures made from plastic materials such as polypropylene and polyethylene for oral solid dosage forms due to their resistance to breakage and compatibility with high-speed filling lines.
The pharmaceutical caps and closures market is estimated to be valued at USD 6.4 Bn in 2024 and is expected to reach USD 10.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.
Key players operating in the pharmaceutical caps and closures are Capsugel, Closure Systems International, AptarGroup, Global Closure Systems, and BERICAP.
The increasing number of new product launches and rising generic drug market provides significant opportunities for Pharmaceutical Caps and Closures Market manufacturers to expand their product portfolio and presence in pharmaceutical packaging. Many caps and closures manufacturers are focusing on expanding their geographic presence by investing in emerging markets of Asia Pacific and Middle East & Africa fueled by growing pharmaceutical production in these regions. Global players are actively pursuing mergers and acquisitions to strengthen their product technology and geographic footprint.
Market drivers Increasing R&D investments by pharmaceutical companies for development of new drugs is a key factor driving the demand for pharmaceutical caps and closures. Novel drugs require specialized packaging solutions to provide product differentiation and ensure safety. This favors adoption of innovative caps and closure designs. Growing prevalence of lifestyle diseases and chronic conditions globally is also propelling the pharmaceutical market growth, in turn boosting the sales of pharmaceutical packaging consumables including caps and closures.
Market restraints Fluctuations in prices of raw materials used for caps and closures production can adversely impact the profit margins of manufacturers. Lack of harmonization in global regulations for pharmaceutical packaging may pose compliance challenges for manufacturers with global operations. Furthermore, switch towards alternative packaging formats such as blisters poses a threat to the caps and closures market to some extent.
Segment Analysis Softgel/pill capsules segment currently accounts for the major share in the market. Soft capsules offer distinct advantages over conventional tablets and are thus gaining popularity across various applications. Their seamless structure allows for smooth digestion and enhanced absorption of active ingredients. Softgel capsules encapsulate liquid, semi-solid, and solid formulations easily and are relatively small in size, facilitating swallowing. This makes them suitable for supplement, health & beauty, and nutraceutical products among others. The hard capsules segment also holds significant share led by wide acceptance in generic drugs. Hard gelatin capsules provide a solid shell for powder or granular ingredients and present an elegant alternative to tablets. However, their usage is limited to dry ingredients only. Nevertheless, they are affordable and offer versatility in customization of shapes, colors, sizes and markings as required.
Global Analysis The North America pharmaceutical caps and closures market will likely maintain dominance during the forecast period. This is due to the large pharmaceutical industry coupled with rising healthcare expenditure in the region. The US, being the largest pharmaceutical market worldwide, witnesses high demand for caps and closures for solid oral drug delivery. Europe holds the second spot led by increasing generic drugs market. Meanwhile, Asia Pacific is anticipated to be the fastest growing regional market in the upcoming years. This growth can be attributed to rising incomes, expanding middle class, and growing healthcare awareness in densely populated economies like India and China.
Get this Report in Japanese Language: 医薬品キャップおよびクロージャー市場
Get this Report in Korean Language: 제약용 캡 및 클로저 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
